RDEA119 and Sorafenib Combination Dose Escalation Study
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Sorafenib
Related studies linked through entity extraction aliases.
A Phase I Trial Evaluating mFOLFOX6 and Avastin With Nexavar as First-Line Treatment for Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Sorafenib Monotherapy in Inoperable/Recurrent Germ Cell Carcinoma Refractory to Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE2
Sorafenib and Transarterial Chemoembolization for Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
PK Trial of Sorafenib & Erlotinib in Patients With Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Sorafenib in Treating Non-Smokers or Former Light Smokers With Relapsed or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Phase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma
- Status
- TERMINATED
- Phase
- PHASE1
Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
- Status
- TERMINATED
- Phase
- NA
A Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Study of SIR-Spheres Plus Sorafenib as 1st Line Treatment for Non-resectable Primary Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study Of Sunitinib Malate Versus Sorafenib In Patients With Inoperable Liver Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Study of Gemcitabine and Erlotinib Plus Sorafenib (GES) in Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Sorafenib in Hormone Naïve Biochemical Recurrence of Prostate Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Phase I Study of Bevacizumab and Sorafenib Combined With Low Dose Cyclophosphamide in Patients With Refractory Solid Tumors and Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Gemcitabine and Sorafenib in Advanced Biliary Tract Cancer (GEMSO)
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination of Sorafenib and Radiation for Brain Metastases and Primary Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Study of Vorinostat and Sorafenib in Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1